1. Targeted Gastrointestinal Delivery of mRNA Lipid Nanoparticles Enables Systemic Vaccination and Glucagon-like Peptide-1 Metabolic Therapy
Abbas Am, Ghanim R, Rudden S, Schultz D, Jang B, Shakked A, Et Al.
Lipid nanoparticles (LNPs) administered parenterally often show poor localization to multiple tissue types, including the pancreas and gastrointestinal (GI) tract. Furthermore, patients typically prefer orally administered drugs to those that are given parenterally. We therefore investigated whether GI LNP…
- GLP-1 mRNA
- Gastrointestinal delivery
- Lipid nanoparticles
- Oral delivery
- Pancreatic delivery
- Vaccine
- mRNA delivery
